Últimos Artículos de Endocrine Related Cancer
- Systemic therapy for advanced pheochromocytoma and paraganglioma: real-world evidence from a single-center cohort
- Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTC
- Nrf2 shapes response to lysosomal inhibition of radiation-induced senescent thyroid cancer cells
- Functional analysis of AIP variants in a cohort of neuroendocrine neoplasms
- Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A
- Elevated vasoactive intestinal peptide concentrations poorly predict VIPoma
- Acknowledgement to reviewers
- Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602)
- Prevalence and clinical characteristics of Lynch syndrome-associated adrenocortical carcinoma
- A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol
- Adrenal tumors in the elderly
- Defining the ATA-2025 ‘consider RAIT’ zone in older patients with N1b PTC
- The prostate is a common site of disease in patients with MEN2B and medullary thyroid carcinoma
- Cryoablation of bone metastases in thyroid and adrenocortical cancers
- The prevalence and clinical significance of 68Ga-DOTANOC incidentaloma
- Expanding horizons in Endocrine-Related Cancer: innovation, imagination, and a shared global vision
- Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience
- Pro-tumoural effects of vitamin C supplementation in a zebrafish model for SDHB-associated PPGL
- Hallmarks of disease: how tuned hierarchies of intelligent molecular neural networks (MNNs) may matter
- Lenvatinib and everolimus synergistically inhibit neuroendocrine neoplasms by upregulating ITGB4 expression